4.4 Article

Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia

Journal

HORMONES AND BEHAVIOR
Volume 128, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yhbeh.2020.104915

Keywords

Schizophrenia; Oxytocin; Social cognition; Sex differences

Funding

  1. United States Department of Veterans Affairs [1IK2CX000758-01A1]
  2. (Office of Academic Affiliations Advanced Research Fellowship Program)
  3. National Institute of Mental Health [R25 MH60482]

Ask authors/readers for more resources

While oxytocin has been shown to improve mentalizing in men with schizophrenia, it did not have the same effect in women with schizophrenia in this study, suggesting potential sex-specific effects. Higher doses of anti-dopaminergic medication were associated with a decreased response to oxytocin, consistent with previous findings in men.
Introduction: Mentalizing, the ability to infer other people's intentions and emotions, is commonly impaired in schizophrenia and may represent an endophenotype. The hypothalamic neuropeptide oxytocin has been shown to improve mentalizing in men with schizophrenia, but its effects in women remain unclear. Given sex differences in the clinical manifestations of schizophrenia and oxytocin system function, this is an important gap to address. Methods: We tested the effects of a single-dose oxytocin challenge (40 IU) on mentalizing task performance among 26 women with schizophrenia and 38 healthy control women using a randomized, placebo-controlled, double-blind, crossover design. We aimed to replicate our prior study of oxytocin effects on mentalizing in men with schizophrenia, using the same oxytocin administration procedures and performance-based assessments. We used mixed-effects models and equivalence testing as well as Bayesian hierarchical models to examine oxytocin effects. Results: In contrast to our previous finding in a male sample, oxytocin did not improve mentalizing in this sample of women with schizophrenia. Exploratory analyses showed that higher anti-dopaminergic medication dosage was associated with a decreased response to oxytocin, consistent with previous findings in men. Conclusion: These findings provide preliminary evidence that exogenous oxytocin administration may have sex-specific effects on mentalizing in schizophrenia. Inclusion of women in future clinical studies with larger samples is critical, as oxytocin effects observed in men may not extend to women with the disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available